Paul Mahon
General Counsel chez UNITED THERAPEUTICS CORPORATION
Fortune : 8 M $ au 31/03/2024
Profil
Paul A.
Mahon is currently the Co-Managing Director at Unither Therapeutik GmbH.
He is also currently serving as the Secretary, Executive VP & General Counsel at United Therapeutics Corp.
and Miromatrix Medical, Inc. In the past, he worked as a Director at SteadyMed Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/04/2024 | 36 710 ( 0,08% ) | 8 M $ | 31/03/2024 |
Postes actifs de Paul Mahon
| Sociétés | Poste | Début |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | General Counsel | 01/01/2001 |
| MIROMATRIX MEDICAL INC. | General Counsel | 11/12/2023 |
Unither Therapeutik GmbH
 Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Part of United Therapeutics Corp., Unither Therapeutik GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Morfelden-Walldorf, Germany. The CEOs of the company are Paul A. Mahon, James Christopher Edgemond. | Chief Executive Officer | - |
Anciens postes connus de Paul Mahon
| Sociétés | Poste | Fin |
|---|---|---|
| STEADYMED LTD | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| MIROMATRIX MEDICAL INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Part of United Therapeutics Corp., Unither Therapeutik GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Morfelden-Walldorf, Germany. The CEOs of the company are Paul A. Mahon, James Christopher Edgemond. | Health Technology |
SteadyMed Ltd.
 SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |
